Immix Biopharma, Inc. IMMX Less: accumulated depreciation and amortization
Less: accumulated depreciation and amortization at other companies
Other financials
Where this comes from
Reported directly by Immix Biopharma, Inc. in its filing.
Tagged under the XBRL concept us-gaap:PropertyPlantAndEquipmentExcludingLessorAssetUnderOperatingLeaseAccumulatedDepreciation.
The official record: Immix Biopharma, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immix Biopharma, Inc.'s less: accumulated depreciation and amortization.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immix Biopharma, Inc.'s less: accumulated depreciation and amortization?
- Immix Biopharma, Inc. (IMMX) reported less: accumulated depreciation and amortization of $384.58K in Q1 2026.
- How has Immix Biopharma, Inc.'s less: accumulated depreciation and amortization changed year-over-year?
- Immix Biopharma, Inc.'s less: accumulated depreciation and amortization increased by 350.3% year-over-year, from $85.41K to $384.58K.
- What is the long-term trend for Immix Biopharma, Inc.'s less: accumulated depreciation and amortization?
- Over 2 years (2023 to 2025), Immix Biopharma, Inc.'s less: accumulated depreciation and amortization has grown at a 352.4% compound annual growth rate (CAGR), from $14.31K to $293K.
- What does less: accumulated depreciation and amortization mean?
- This is the cumulative amount of depreciation and amortization recorded against the company's tangible assets over their useful lives. It reflects the reduction in the book value of physical assets due to wear, tear, and obsolescence, providing insight into the age and condition of the company's infrastructure.